Village Farms International, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Village Farms International, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.94M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $195.91M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $163.11M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $293.57M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $268.02M | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | $170.09M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $144.57M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $150.00M | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $158.41M | Apr 1, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $87.68M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $45.80M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $47.95M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $27.50M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $45.18M | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | $10.96M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | ($7.35M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $9.32M | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $13.97M | Apr 1, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.44M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($35.85M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($34.80M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | ($101.15M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | ($9.08M) | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | $11.61M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $2.33M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | ($7.52M) | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | ($4.76M) | Apr 1, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.29M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $61.75M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $56.71M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $72.27M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $53.92M | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | $19.09M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $16.76M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $14.11M | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $14.88M | Apr 1, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $10.35M | Mar 13, 2025 |
| FY2024 | Dec 31, 2023 | $5.32M | Mar 13, 2025 |
| FY2024 | Dec 31, 2022 | ($19.89M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | ($39.57M) | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | $5.68M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | ($14.39M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | ($4.68M) | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $669.0K | Apr 1, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.22M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $7.17M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $3.60M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $14.29M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $21.66M | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | $3.42M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $2.29M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $3.09M | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.70M | Apr 1, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $423.10M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $389.31M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $463.99M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $465.29M | Jun 24, 2024 |
| FY2021 | Dec 31, 2021 | $566.91M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $354.03M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $183.41M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $141.45M | Apr 1, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $113.03M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $125.35M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $148.05M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $145.29M | Jun 24, 2024 |
| FY2021 | Dec 31, 2021 | $142.07M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $148.75M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $56.95M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $57.02M | Apr 1, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $254.01M | Mar 13, 2025 |
| FY2024 | Dec 31, 2023 | $299.63M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $303.06M | Jun 24, 2024 |
| FY2021 | Dec 31, 2021 | $408.41M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $205.28M | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | $126.46M | Mar 1, 2022 |
| FY2021 | Dec 31, 2018 | $84.43M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $66.89M | Mar 19, 2021 |
| FY2019 | Dec 31, 2016 | $60.00M | Apr 1, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.37M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $42.32M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $55.92M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $66.23M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $117.53M | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | $24.03M | Mar 1, 2022 |
| FY2020 | Nov 2, 2020 | $23.10M | Mar 19, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($112.58M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($145.02M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($109.17M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($74.37M) | Jun 24, 2024 |
| FY2021 | Dec 31, 2021 | $26.78M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $35.86M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $24.25M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $21.93M | Apr 1, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.19M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $24.63M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $30.29M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $16.68M | Jun 24, 2024 |
| FY2021 | Dec 31, 2021 | $53.42M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $21.64M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $11.99M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $11.92M | Apr 1, 2020 |
| FY2019 | Dec 31, 2017 | $7.09M | Apr 1, 2020 |
| FY2019 | Dec 31, 2016 | $5.37M | Apr 1, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.65M | Mar 12, 2026 |
| FY2024 | Dec 31, 2024 | $40.56M | Mar 13, 2025 |
| FY2023 | Dec 31, 2023 | $48.06M | Jun 24, 2024 |
| FY2021 | Dec 31, 2022 | $60.14M | Mar 9, 2023 |
| FY2021 | Dec 31, 2021 | $67.28M | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | $68.58M | Mar 19, 2021 |
| FY2019 | Dec 31, 2019 | $32.39M | Apr 1, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Apr 1, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Jun 24, 2024 |
| FY2021 | Dec 31, 2020 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Apr 1, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 115.72M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 112.34M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 110.25M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | 91.79M | Jun 24, 2024 |
| FY2021 | Dec 31, 2021 | 88.23M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | 66.91M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 52.66M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | 47.64M | Apr 1, 2020 |